The Sir Ganga Ram Hospital on Tuesday started administering monoclonal antibody cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness, it added.
The MRP of one MAC dose for a patient is Rs 59,750, the statement said.
According to the Drug Controller General of India (DCGI), selection of patients will entail that they have Covid positive test report, mild to moderate Covid disease, are in the age group of 12 and above and weighing at least 40 kg, and are at high risk of COVID-19.
Dr DS Rana, Chairman (BOM), Sir Ganga Ram Hospital said, “As per the claims of the company Roche/ Cipla, we hope MAC will be a major factor in the fight against COVID-19 to prevent disease from progressing to further severity.”
(Cover: Representational / Credit – Getty Images)
RWAs urge residents to keep exits and escape routes unobstructed, stressing basic fire safety, maintenance,…
Silver rallies sharply on strong domestic demand, while gold slips amid firm dollar, rising yields…
Sharp rise in fire calls in April linked to heat and waste fires; 32 deaths…
A 26-year-old man linked to an interstate ATM gang was arrested after allegedly looting Rs…
A jeweller was robbed at gunpoint of 75 gm gold, Rs 3 lakh cash and…
CM reviews preparations for India-Africa Forum, Big Cat Alliance summits, calls for high-level arrangements and…
